Is GAP or CRI a better buy right now?

Based on our latest analysis, CRI is currently the stronger investment candidate based on our comprehensive scoring model.

Does GAP or CRI have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: GAP or CRI?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, GAP or CRI?

As of Oct 16, 2026, CRI scores higher in our model: GAP has an AI score of 39.4 versus 42.8 for CRI. GAP is currently in a Markup technical phase and CRI is in a Neutral phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are GAP and CRI in?

GAP is in a Markup phase (Hold / add on dips) with an RSI of 51.5. CRI is in a Neutral phase (Hold) with an RSI of 56.7.

GAP vs CRI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

GAP

39.4

AI Score

CRI Wins

CRI

42.8

AI Score

Investment Advisor Scores

GAP

39score

Recommendation

SELL

View Full Analysis

CRI

43score

Recommendation

HOLD

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	GAP	CRI	Winner
Revenue	7.15B	1.30B	GAP
Net Income	840.00M	119.29M	GAP
Gross Margin	46.8%	54.5%	CRI
Net Margin	11.8%	9.2%	GAP
Operating Income	1.12B	168.27M	GAP
ROE	21.3%	11.6%	GAP
ROA	6.5%	4.4%	GAP
Total Assets	12.86B	2.73B	GAP
Cash	2.10B	653.57M	GAP
Debt/Equity	0.38	0.55	GAP
Current Ratio	1.82	2.47	CRI
Free Cash Flow	261.00M	189.50M	GAP

Relative Price Performance (Last 90 Days)

GAP 1M: +7.0% · 3M: +19.8% CRI 1M: +13.1% · 3M: -13.1%

Current Technical Phase

GAP

Markup

Hold / add on dips

Price above SMA50, rising 50-day trend (5.5% over 20 days), RSI 51

RSI (14): 51.5 · Price: $22.78

CRI

Neutral

Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.7 · Price: $33.67

Fundamentals Snapshot

Metric	GAP	CRI
Market Cap	—	—
Forward P/E	9.7	9.4
Trailing P/E	7.1	6.3
Revenue (TTM)	—	—
Revenue Growth	0.0%	0.1%
Gross Margin	0.4%	0.5%
Operating Margin	0.1%	0.2%
EPS	3.32	5.36
Dividend Yield	0.03%	0.03%

Frequently Asked Questions

Based on our detailed analysis, CRI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

GAP

CRI

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Oct 16, 2026 10:30 UTC. Refresh Data

Tradestie